Inge Van Haute

667 total citations
10 papers, 426 citations indexed

About

Inge Van Haute is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Inge Van Haute has authored 10 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Inge Van Haute's work include Mesenchymal stem cell research (2 papers), Platelet Disorders and Treatments (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Inge Van Haute is often cited by papers focused on Mesenchymal stem cell research (2 papers), Platelet Disorders and Treatments (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Inge Van Haute collaborates with scholars based in Belgium, Greece and United States. Inge Van Haute's co-authors include Bart Vandekerckhove, Marc Vanderheyden, Samer Mansour, Guy R. Heyndrickx, Nele Lootens, Jozef Bartúnek, William Wijns, Bernard De Bruyne, Pieter De Bondt and Frank Timmermans and has published in prestigious journals such as Circulation, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

Inge Van Haute

9 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Van Haute Belgium 5 271 271 180 116 75 10 426
Nele Lootens Belgium 2 248 0.9× 247 0.9× 161 0.9× 106 0.9× 69 0.9× 3 378
Oliver Gutiérrez Spain 8 294 1.1× 277 1.0× 157 0.9× 132 1.1× 92 1.2× 10 489
Goditha U. Premaratne Japan 9 259 1.0× 175 0.6× 119 0.7× 122 1.1× 67 0.9× 17 381
Takeshiro Fujii Japan 10 308 1.1× 172 0.6× 128 0.7× 137 1.2× 83 1.1× 40 454
Gustavo A. Lopera United States 5 207 0.8× 151 0.6× 90 0.5× 93 0.8× 82 1.1× 5 326
Eutychios Voridis Greece 8 256 0.9× 189 0.7× 104 0.6× 106 0.9× 105 1.4× 12 416
Hans Dieter Kleine Germany 9 202 0.7× 214 0.8× 213 1.2× 64 0.6× 138 1.8× 11 469
Marc Vanderheyden Belgium 3 357 1.3× 289 1.1× 202 1.1× 153 1.3× 94 1.3× 6 490
Piotr Bręborowicz Poland 5 311 1.1× 269 1.0× 197 1.1× 110 0.9× 131 1.7× 14 461
Aljaž Sočan Slovenia 8 285 1.1× 137 0.5× 191 1.1× 63 0.5× 131 1.7× 15 505

Countries citing papers authored by Inge Van Haute

Since Specialization
Citations

This map shows the geographic impact of Inge Van Haute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Van Haute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Van Haute more than expected).

Fields of papers citing papers by Inge Van Haute

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Van Haute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Van Haute. The network helps show where Inge Van Haute may publish in the future.

Co-authorship network of co-authors of Inge Van Haute

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Van Haute. A scholar is included among the top collaborators of Inge Van Haute based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Van Haute. Inge Van Haute is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Decaestecker, Jochen, et al.. (2026). “Effect of direct oral anticoagulants in cirrhosis: an in vitro study”: comment. Journal of Thrombosis and Haemostasis. 24(3). 1197–1202.
2.
Haute, Inge Van, et al.. (2016). Diagnostic Challenges in Acquired von Willebrand Syndrome: A Complex Case of Prostate Carcinoma Associated-Acquired von Willebrand Syndrome. Seminars in Thrombosis and Hemostasis. 43(1). 101–104. 5 indexed citations
3.
Haute, Inge Van, et al.. (2016). Diagnostic Challenges in Acquired von Willebrand Disease: A Complex Case of Prostate Carcinoma. Journal of Hematology. 5(3). 110–112. 1 indexed citations
4.
Moreau, E, et al.. (2015). Minimal Coexpression of CD34+/CD56+ in Acute Promyelocytic Leukemia Is Associated With Relapse. American Journal of Clinical Pathology. 144(2). 347–351. 5 indexed citations
6.
Haute, Inge Van, et al.. (2006). Therapeutic efficacy and safety of transfusion of pathogen-inactivated platelets tot pediatric patients. Ghent University Academic Bibliography (Ghent University). 4 indexed citations
7.
Bartúnek, Jozef, Marc Vanderheyden, Bart Vandekerckhove, et al.. (2005). Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction. Circulation. 112(9_supplement). I178–83. 352 indexed citations
8.
Haute, Inge Van, et al.. (2004). Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?. Transfusion. 44(4). 547–554. 25 indexed citations
9.
Haute, Inge Van, et al.. (2004). The above letter was sent to Vandekerckhove et al.; Drs Vandekerckhove and Van haute offered the following reply.. Transfusion. 45(1). 118–119. 1 indexed citations
10.
Benoît, Yves, et al.. (2004). Safety and Efficacy of Pathogen-Inactivated Platelets Transfused in Routine Use to Pediatric Patients: An Interim Report.. Blood. 104(11). 3639–3639. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026